  See all
 |
Articles: Hepatobiliary/Pancreas |
Prior Articles
LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma
Journal of Cancer Research & Clinical Oncology, 08/26/09
Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1alpha involvement in CYP3A4 repression
European Journal of Cancer, 08/25/09 Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer
Journal of Clinical Oncology, 08/24/09 Biliary intraepithelial neoplasia in patients without chronic biliary disease
Cancer, 08/21/09 The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula
Cancer, 08/21/09 The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium
Investigational New Drugs, 08/20/09 Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma
International Journal of Cancer, 08/20/09 Reexpression of Human Somatostatin Receptor Gene 2 Gene Mediated by Oncolytic Adenovirus Increases Antitumor Activity of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand against Pancreatic Cancer
Clinical Cancer Research, 08/20/09 A cohort study of the risk of cancer associated with type 2 diabetes
British Journal of Cancer, 08/20/09 A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
British Journal of Cancer, 08/20/09 Perivascular epithelioid cell tumor (PEComa) of the pancreas: Immunoelectron microscopy and review of the literature
Pathology International, 08/20/09 Molecular pathology of early stage chemically induced hepatocarcinogenesis
Pathology International, 08/20/09 Genetic and Nongenetic Covariates of Pain Severity in Patients with Adenocarcinoma of the Pancreas: Assessing the Influence of Cytokine Genes
Journal of Pain and Symptom Management, 08/20/09 Serum cholesterol levels in relation to the incidence of cancer: The JPHC study cohorts
International Journal of Cancer, 08/19/09 Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-[kappa]B
International Journal of Cancer, 08/19/09 Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors)
Human Pathology, 08/19/09 Up-regulation of mir-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
Cancer Research, 08/18/09 Novel treatments for hepatocellular cancer
Cancer Letters, 08/18/09
Revew Article
IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas
Human Pathology, 08/18/09 Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma
Human Pathology, 08/18/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
